Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

YM178 Phase II study - A Randomized, Double-blind, Parallel-group, Placebo-controlled Study in Patients With Symptomatic Overactive Bladder
mirabegron
178-CL-045
NCT00527033
Urinary Bladder, Overactive
Phase 2
 
October 2016

Powered by ideaPoint, Inc.